Collaboration expands Immuto’s structural surfaceomics platform into immunology and inflammation to uncover novel disease-associated dermatology targets for animal health CAMBRIDGE, Mass. & MADISON, ...
In disease, protein shapes and interactions can change in ways that traditional genomics and proteomics rarely capture. Dr. Faraz A. Choudhury, co-founder and CEO of Immuto Scientific, recognized this ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min A Madison, Wisconsin-based ...
Immuto Scientific Inc. has closed an $8 million seed 2 financing round and entered into a drug discovery collaboration with Daiichi Sankyo Co. Ltd. Immuto applies its target discovery platform and ...
CAMBRIDGE, Mass. & MADISON, Wis.--(BUSINESS WIRE)--Immuto Scientific announced today a collaborative agreement with the University of Wisconsin–Madison to identify disease-specific, novel therapeutic ...
Subscribe to BizTimes Daily – Local news about the people, companies and issues that impact business in Milwaukee and Southeast Wisconsin. Immuto Scientific’s Plasma Induced Modification of ...
MADISON (WKOW)— The University of Wisconsin–Madison and Immuto Scientific have teamed up to explore new therapeutic targets in colorectal cancer. According to the University of Wisconsin School of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results